Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Chipscreen Biosciences, Ltd.
Stanford University
Cure 51